Diabetes mellitus tipo 2: una problemática actual de salud en la población pediátrica
Files
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
View full text
Date
Subject
Type 2 diabetes mellitus
obesity
teen
kid
diabetes mellitus tipo 2
obesidad; niño
adolescente
obesity
teen
kid
diabetes mellitus tipo 2
obesidad; niño
adolescente
Language:
Journal Title
Journal ISSN
Volume Title
Publisher
Intituto Tecnológico de Santo Domingo (INTEC)
La diabetes mellitus tipo 2 resulta de la combinación de resistencia a la insulina junto con inadecuada secreción de la misma. Su etiología es heterogénea, implicándose en los mismos, factores genéticos y ambientales. Su incremento ha sido significativo en las últimas décadas lo cual ha estado aparejado al incremento de la obesidad. Pudiendo existir tres formas de presentación: asintomática, sintomática y cetosis o cetoacidosis.
El desarrollo acelerado de las complicaciones está dado por una disminución más rápida y progresiva de la función de las células B que caracteriza esta enfermedad en la edad pediátrica.
El tratamiento incluye cambios del estilo de vida, el auto-control de la diabetes y el tratamiento farmacológico, siendo esencial involucrar a toda la familia en el manejo de este grupo de pacientes. Solo la metformina y la insulina han sido aprobadas para su utilización en este grupo de edad.
La prevención es la piedra angular para frenar la oleada de DM2 en niños y adolescentes a nivel internacional. Se basa en la identificación de los individuos en riesgo, diag-nóstico precoz de estados prediabéticos y la educación, dirigida a la familia y a la comunidad.
Type 2 diabetes mellitus results from the combination of insulin resistance along with inadequate secretion of it. Its etiology is heterogeneous, involving genetic and environ-mental factors. Its increase has been significant in recent decades which has been coupled with the increase in obesity. There may be three forms of presentation: asymptomatic, symptomatic and ketosis or ketoacidosis. The accelerated development of complications is due to a more rapid and progressive decrease in the function of the B cells that characterizes this disease in the pediatric age. The treatment includes lifestyle changes, diabetes self-control and drug treatment, being essential to involve the whole family in the management of this group of patients. Only metformin and insulin have been approved for use in this age group. Prevention is the cornerstone to curb the surge of DM2 in children and adolescents internationally. It is based on the identification of individuals at risk, early diagnosis of prediabetic states and education, aimed at the family and the community.
Type 2 diabetes mellitus results from the combination of insulin resistance along with inadequate secretion of it. Its etiology is heterogeneous, involving genetic and environ-mental factors. Its increase has been significant in recent decades which has been coupled with the increase in obesity. There may be three forms of presentation: asymptomatic, symptomatic and ketosis or ketoacidosis. The accelerated development of complications is due to a more rapid and progressive decrease in the function of the B cells that characterizes this disease in the pediatric age. The treatment includes lifestyle changes, diabetes self-control and drug treatment, being essential to involve the whole family in the management of this group of patients. Only metformin and insulin have been approved for use in this age group. Prevention is the cornerstone to curb the surge of DM2 in children and adolescents internationally. It is based on the identification of individuals at risk, early diagnosis of prediabetic states and education, aimed at the family and the community.
Description
Type
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/publishedVersion
Source
Science and Health; Vol 4 No 1 (2020): Science and Health, january-april; 17-26
Ciencia y Salud; Vol. 4 Núm. 1 (2020): Ciencia y Salud, enero-abril; 17-26
2613-8824
2613-8816
10.22206/cysa.2020.v4i1
Ciencia y Salud; Vol. 4 Núm. 1 (2020): Ciencia y Salud, enero-abril; 17-26
2613-8824
2613-8816
10.22206/cysa.2020.v4i1